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ABSTRACT
Introduction: Adverse events in hospitals constitute a
serious problem with grave consequences. Many studies
have been conducted to gain an insight into this problem,
but a general overview of the data is lacking. We
performed a systematic review of the literature on in-
hospital adverse events.
Methods: A formal search of Embase, Cochrane and
Medline was performed. Studies were reviewed inde-
pendently for methodology, inclusion and exclusion
criteria and endpoints. Primary endpoints were incidence
of in-hospital adverse events and percentage of prevent-
ability. Secondary endpoints were adverse event outcome
and subdivision by provider of care, location and type of
event.
Results: Eight studies including a total of 74 485 patient
records were selected. The median overall incidence of in-
hospital adverse events was 9.2%, with a median
percentage of preventability of 43.5%. More than half
(56.3%) of patients experienced no or minor disability,
whereas 7.4% of events were lethal. Operation- (39.6%)
and medication-related (15.1%) events constituted the
majority. We present a summary of evidence-based
interventions aimed at these categories of events.
Conclusions: Adverse events during hospital admission
affect nearly one out of 10 patients. A substantial part of
these events are preventable. Since a large proportion of
the in-hospital events are operation- or drug-related,
interventions aimed at preventing these events have the
potential to make a substantial difference.
Adverse events (AEs) in hospitals are now widely
agreed to be a serious problem, annually killing
more people than breast cancer or AIDS.
1 An AE is
usually defined as an unintended injury or com-
plication resulting in prolonged hospital stay,
disability at the time of discharge or death and
caused by healthcare management rather than by
the patient’s underlying disease process.
23 Aside
from the direct harm to the patient, AEs are a
considerable financial burden to the healthcare
system. In 1999, it was estimated that the total
costs of preventable AEs in the USA lie between
$17 billion and $29 billion annually.
4
In recent years, the focus in thinking about AEs
has shifted from the person approach—blaming
individuals for errors—to the systems approach.
The systems approach assumes that people will
make mistakes, and that the system that surrounds
them should provide a safety net for these
mistakes. Therefore, efforts to eliminate AEs
should be directed towards a particular system.
5
This new approach has shifted the focus of the
debate on AEs from the legal consequences
associated with personal responsibility, to a more
constructive point of view, clearing the way for
thinking about solutions.
In the aftermath of the 2001 Institute of
Medicine report ‘‘To err is human,’’
1 many large
studies have been performed concerning AEs, some
of them nationwide. Although many of these
studies used similar methods, they report substan-
tially different incidences. A general overview of
data on in-hospital AEs is lacking.
To make the important step towards solutions,
it is necessary to gain a more detailed under-
standing of this problem: what percentage of
events is preventable, where do the majority of
events happen and which type of event is the most
frequent? This will enable identification of cate-
gories of AEs that are most susceptible to inter-
ventions to improve patient safety.
To gain an insight into the overall incidence,
preventability, outcome and subdivision by loca-
tion, provider and type of in-hospital AEs and the
evidence related to relevant patient safety inter-
ventions, we conducted a systematic review of
available data from the literature.
METHODS
Literature search
Two authors(ENV,MAB)independentlyperformed
a formal computer-assisted search of the medical
databases Medline (January 1966 to February 2007),
CochraneandEmbase(January1980toFebruary2007).
Keywords used were ‘‘adverse events’’ and ‘‘pre-
ventable.’’ Clinical studies published in peer-
reviewed journals in the English language were
identified. A manual cross-reference search of the
eligible papers was performed to identify additional
relevant articles.
Selection
In order to be able to reliably compare the data, we
defined an AE as follows: an unintended injury or
complication resulting in prolonged hospital stay,
disability at the time of discharge or death and
caused by healthcare management rather than by
the patient’s underlying disease process. All studies
that used this or a similar definition to evaluate the
incidence of AEs in adult hospital patients and that
included a minimum of 1000 patient records were
eligible for inclusion. Studies that evaluated errors
without linking them to outcomes and studies
relying only on computerised screening data were
excluded. Studies that evaluated specific types of
AEs only (for example, adverse drug events only)
and studies that evaluated specific populations (for
example, ICU patients only) were excluded. No
abstract publications without subsequent full-text
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resolved in a consensus meeting.
Validity assessment
Two authors (ENV, MAB) independently assessed selected
studies for methodology and endpoints. Information was
extracted on the methods of data collection (prospective or
retrospective), record selection and review, the time frame of
included AEs and recorded interobserver variability. Primary
endpoints were the incidence of AEs and the percentage of
preventability. Secondary endpoints were adverse event out-
come and subdivision by provider of care, location and type of
event.
Data collection
Data on incidence of AEs, preventability, outcome, location,
provider of care and type of event were extracted. Whenever
possible, raw data were used, and percentages were calculated.
Extrapolations to state or country levels were not reproduced.
Data on outcome, provider of care, location and type of event
were grouped into common categories that the majority of
articles used.
Interventions
After analysis of the data yielded the categories of events that
were responsible for the majority of adverse events, a computer-
assisted search of Medline was performed to identify interven-
tions relating to these categories of events. Only studies with a
level of evidence of one or two were included.
Statistical analysis
Medians and interquartile ranges (IQR) of incidence, prevent-
ability, and the different categories of outcome, location, provider
of care and type of event were calculated using Statistical Package
for the Social Sciences version 12.0 (SPSS, Chicago).
RESULTS
Article retrieval
The initial search yielded 257 articles (fig 1). After reviewing the
titles and abstracts, 228 articles were excluded. These articles
included reviews, studies on specific types of AEs only, for
example adverse drug events, and studies in specific popula-
tions, for example children or ICU patients. Of the remaining 29
studies, another 17 were excluded after reviewing the full article.
Three of these studies applied a different definition of an AE; one
study used an observational approach and recorded only errors
without linking them to outcomes;
6 the other two studies used a
computer-assisted approach to screen a large number of patient
records for certain codes denoting complications.
78Three studies
were excluded because of an insufficient number of patient
records; one of these studies used retrospective record review;
9
the other studies would otherwise have been excluded due to
methodological designs that differed from the large record review
studies.
10 11 Five studies presented data of patient populations
already included in other publications,
12–16 and six studies
presented insufficient data on the primary endpoint.
17–22
Included studies
We included 12 articles in the review. Of these articles, four
reported additional data of patient populations that were
already included.
23–26 In this review, these articles were
considered as one study together with the article first published,
resulting in eight reviewed studies.
Study characteristics
Characteristics of included studies are presented in tables 1 and
2. A total of 74 485 patient records were derived from the
included studies. The number of hospitals per study ranged
from 1 to 51 and the median number of patient records
reviewed per study was 5162 (IQR 1542–14 569). All studies
used a two-stage retrospective record review technique. Records
were first screened by trained nurses; when positive for certain
Figure 1 Flow chart of article retrieval.
AE, adverse event.
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27 (for example an unplanned readmission, an
adverse drug reaction or a hospital-acquired infection), the
records were then reviewed by a physician to determine
whether or not an AE had occurred. In two studies, the data
from this approach were compared with voluntary reporting
data.
28 29 Whether or not an event was caused by healthcare
management (causality judgement) was measured on a
six-point scale in six studies; a score of >2
33 0or >4
2 31–33 was
considered positive. The other two studies did not specify the
details of the causality judgement.
28 29 Of the six studies that
gave a judgement on preventability, four used a similar six-point
scale; a score of >4 was considered preventable.
32 42 83 1 The
other two studies did not specify the details of the prevent-
ability judgement.
29 33
Table 1 Included studies
Reference Year of publication Country No. of hospitals No. of records Inclusion period Study design
1. Brennan et al
25 32 1991 USA 51 30 121 1984 Retrospective record review
2. O’Neil et al
23 28 1993 USA 1 3141 1990–1991 Retrospective record review and
review of voluntary reporting data
3. Wilson et al
3 1995 Australia 28 14 179 1992 Retrospective record review
4. Thomas et al
2 2000 USA 28 14 700 1992 Retrospective record review
5. Vincent et al
26 33 2001 UK 2 1014 1998 Retrospective record review
6. Davis et al
24 30 2002 New Zealand 13 6579 1998 Retrospective record review
7. Baker et al
31 2004 Canada 20 3745 2000 Retrospective record review
8. Sari et al
29 2006 UK 1 1006 2004 Retrospective record review and
review of voluntary reporting data
Table 2 Study characteristics
Reference Population
Method of record
selection Method of review
More than
one adverse
event per
patient?
Time frame of
included events
Kappa value for
interobserver
agreement Endpoints
1. Brennan et al
25 32 Acute-care hospital
patients (no
psychiatric patients)
Random sample of
hospitalisations from
51 hospitals
Two-stage record review: first,
screening for one of 18 criteria
by trained nurses; second,
review by two physicians
Not
specified
Occurred before
and during and
detected during
index admission
0.61 Incidence,
negligence,
outcome, location,
type of event
2. O’Neil et al
23 28 Hospital patients All admissions to
the medical service
of one hospital over
a 4-month period
1. Two-stage record review:
first, screening for one of 15
criteria by medical-record
analysts; second, review by
physician
No Not specified 0.57 Incidence,
preventability
2. Reviewing reported incidents
3. Wilson et al
3 Acute-care hospital
patients (no
psychiatric or
day-care patients)
Random sample of
admissions from 28
hospitals
Two-stage record review: first,
screening for one of 18 criteria
by trained nurses; second,
review by two medical officers
No Occurred before*
and during and
detected during or
after index admission
0.55 Incidence,
preventability,
outcome, provider
of care, location,
type of event
4. Thomas et al
2 Hospital patients
(no psychiatric,
rehabilitation or
drug/alcohol
treatment patients)
Random sample of
discharges from 28
hospitals
Two-stage record review: first,
screening for one of 15 criteria
by trained nurses; second,
review by physician
No Occurred before
and during and
detected during
index admission
0.4 Incidence,
negligence,
outcome, provider
of care, location,
type of event
5. Vincent et al
26 33 Acute hospital
patients (general
medicine, general
surgery, orthopaedic
surgery, obstetrics)
Records randomly
drawn from two
hospitals
Two-stage record review: first,
screening for one of 18 criteria
by trained nurses; second,
review by clinician
Yes Not specified Not specified Incidence,
preventability,
outcome, provider
of care, type of
event
6. Davis et al
24 30 Hospital patients
(no psychiatric,
day-care or
rehabilitation
patients)
Random sample of
admissions from 13
hospitals
Two-stage record review: first,
screening for one of 18 criteria
by trained nurses; second,
review by medical officer
Not
specified
Occurred before*
and during and
detected during
index admission
0.47 Incidence,
preventability,
outcome, provider
of care, location,
type of event
7. Baker et al
31 Hospital patients
(no paediatric,
psychiatric, obstetric
or rehabilitative)
Random sample of
admissions from 20
hospitals
Two-stage record review: first,
screening for one of 18 criteria
by trained nurses; second,
review by physician
Yes Occurred before
and during and
detected during
or after index
admission{
0.47/0.45/0.69{ Incidence,
preventability,
outcome, provider
of care, type of
event
8. Sari et al
29 Hospital patients
(surgery, general
medicine, elderly
care, orthopaedics,
urology, oncology,
ENT, ophthalmology)
Random sample of
admissions in one
hospital
1. Two-stage record review:
first, screening for one of 18
criteria by trained nurses;
second, review by physician
Yes Not specified 0.76 Incidence
2. Reviewing reported incidents
*Only included if (partly) responsible for index admission.
{Only included if occurred/was detected during a hospital admission.
{Kappa values for interobserver agreement of judgement on injury/causation/preventability.
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The data on incidence, preventability and outcome of case
record review studies are shown in table 3. The median
incidence of AEs was 9.2% (IQR 4.6–12.4%). The median
percentage of AEs that was judged preventable was 43.5% (IQR
39.4–49.6%). Two studies judged negligence instead of prevent-
ability,
23 2which was defined as AEs caused by a failure to meet
standards reasonably expected of the average physician or
institution. Negligence data were not considered in the
calculation of the median percentage of preventability.
Outcome data were divided into five categories: no or minor
disability (resolved within 1 month), temporary disability
(resolved within 1 year), permanent disability, death and
unknown. The median percentage of AEs that led to no or
minor disability was 56.3% (IQR 51.4–62.8%). Permanent
disability was found in 7.0% (IQR 6.1–11.0%) of patients
experiencing an AE, while 7.4% (IQR 4.7–14.2%) of AEs caused
the death of the patient.
Providers of care
Providers of care were divided into three groups (table 4):
surgical, containing all surgical professions, anaesthesiology,
gynaecology and obstetrics; medicine, containing all internal
specialties and paediatrics; and ‘‘other,’’ containing for example
family practice, nursing and emergency medicine. The median
proportion of AEs associated with surgical providers was 58.4%
(IQR 54.5–70.9%) versus 24.1% (IQR 18.7–40.4%) for medical
providers.
Locations
Table 5 shows the various locations where AEs took place. For
all AEs, 80.8% (IQR 75.6–83.2%) were encountered in hospital,
versus 14.9% (IQR 12.9–18.7%) out of hospital before admission
or after discharge. The majority of events were seen in the
operating room (41.0% (IQR 39.5–45.8%)) or the patient’s
room (24.5% (IQR 21.6–26.5%)). By contrast, only 3.1%
(IQR 2.7–3.5%) of AEs were located in the complex environ-
ment of the intensive care unit. The emergency room accounted
for 3.0% (IQR 2.9–3.0%) of AEs.
Type of event
Finally, the AEs were classified according to type of event
(table 6). In three studies an AE could be attributed to more than
one category,
32 43 1 whereas in the other studies, the types of
eventsweremutuallyexclusive.Importantly,approximately50%
of AEs are operation- or drug-related: 39.6% (IQR 31.5–50.2%)
and 15.1% (11.9–20.4%), respectively. By contrast, anaesthesia-
related events formed only 2.0% (IQR 1.2–3.7%) of AEs.
Patient safety interventions
Table 7 gives an overview of the top level (level of evidence 1
and 2) of evidence-based interventions directed towards the
major types of adverse events: operation- and medication-
related events. The operation-related interventions include a
number of medical interventions such as perioperative beta-
blockade and antibiotic prophylaxis. In addition, interventions
Table 3 Adverse events, preventability and outcome
Reference Brennan et al
32 O’Neil et al
23 28 Wilson et al
3 Thomas et al
2 Vincent eta l
33 Davis et al
24 30 Baker et al
31 Sari et al
29
Median
percentage
(interquartile
range)
No. of records 30 121 3141 14 179 14 700 1014 6579 3745 1006 –
No. of patients with at
least one adverse event
1133 (3.8) 237* (7.5) 2353 (16.6) 475 (3.2) 110 (10.8) 850 (12.9) 255 (6.8) 110 (10.9) 9.2 (4.6 to 12.4)
No. of adverse events
(if .1 adverse event
per patient)
– – – – 119 (11.7) – 289 (7.7) 136 (13.5) 11.7 (7.7 to
13.5)
No. of preventable
adverse events
– 103* (43.5) 1205 (51.2) – 57 (47.9) 315 (37.1) 106 (41.6) – 43.5 (39.4 to
49.6)
Outcome
No or minor disability{ 644 (56.8) – 1073 (45.6) 253 (53.3) 73 (66.4) 524 (61.6) 161 (55.7) – 56.3 (51.4 to
62.8)
Temporary disability{ 187 (16.5) – 702 (29.8) 150 (31.6) 21 (19.1) 162 (19.0) 36 (12.5) – 19.1 (15.5 to
30.3)
Permanent disability1 74 (6.5) – 315 (13.4) 40 (8.4) 7 (6.4) 87 (10.2) 15 (5.2) – 7.0 (6.1 to 11.0)
Death 154 (13.6) – 112 (4.8) 31 (6.6) 9 (8.2) 38 (4.5) 46 (15.9) – 7.4 (4.7 to 14.2)
Unknown 75 (6.6) – 151 (6.4) – – 40 (4.7) 31 (10.7) – 6.5 (5.1 to 9.7)
Numbers (percentages) except last column. Interquartile range=25th to 75th percentile. Brennan: no. of records, number of AEs and percentages of outcomes were given.
Percentage of AEs and numbers of outcomes were calculated. No number or percentage was given for preventability. No. of AEs with negligence (failure to meet standards
reasonably to be expected) was 280 (24.7%). O’Neil: two different strategies were used. No. of records, number and percentage of AEs per strategy and percentage of preventability
per strategy were given. Total number and percentage of AEs and total number and percentage of preventable AEs were calculated. Bates: no. of records, number of AEs and
percentage of AEs were given. Wilson: no. of records, number and percentage of AEs, percentage of preventability and numbers were given. No. of preventable AEs and
percentages of outcomes were calculated. Thomas: no. of records, number of AEs and percentages of outcomes were given. Percentage of AEs and numbers of outcomes were
calculated. No number or percentage was given for preventability. Percentage of AEs with negligence (failure to meet standards reasonably to be expected) was 32.6 for Utah and
27.5 for Colorado. Vincent: no. of records, number and percentage of AEs, number and percentage of preventability and numbers and percentages of outcomes were given. Davis:
no. of records, number and percentage of AEs, number and percentage of preventability and percentages of outcomes were given. Numbers of outcomes were calculated. Baker: no.
of records, number of AEs, number and percentage of preventability and numbers and percentages of outcomes were given. Percentage of AEs was calculated. Sari: two different
strategies were used, numbers and percentages in table are combined results. No. of records and number of AEs were given. Percentage of AEs was calculated.
*O’Neil et al used two different strategies. Bates et al evaluated the same population using the same methods for retrospective record review and reported another incidence. The
numbers and percentages given here represent the mean of the combined results from the publication by O’Neil et al and the results by Bates et al. Idem for the preventability
numbers.
{No disability or disability resolved within 1 month; contains Thomas’ categories of ‘‘emotional,’’ ‘‘insignificant’’ and ‘‘minor temporary’’ and Baker’s categories of ‘‘none’’ and ‘‘minimal.’’
{Contains Brennan’s categories of ‘‘disability resolved within 1–6 months’’ and ‘‘within 6–12 months,’’ Thomas’ category of ‘‘major temporary’’ and Baker’s categories of
‘‘impairment resolved within 1–6 months’’ and ‘‘within 6–12 months.’’
1Contains Thomas’ categories of ‘‘minor permanent,’’ ‘‘significant permanent,’’ ‘‘major permanent’’ and ‘‘grave.’’
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Reference Wilson et al
3 Thomas et al
2 Vincent et al
26 Davis et al
24 Baker et al
31
Median percentage
(interquartile range)
No. of adverse event/total no. of records 2353/14 179 475/14 700 119/1 014 850/6 579 289/3 745 –
Surgical 1375 (58.4) 298 (62.7) 94 (79.0) 489 (57.5) 149 (51.4) 58.4 (54.5 to 70.9)
Surgery not otherwise specified – 219 (46.1) – – – –
General surgery 317 (13.5) – 47 (39.5) – – 26.5 (13.5 to 39.5)
Orthopaedic surgery 285 (12.1) – 40 (33.6) – – 22.9 (12.1 to 33.6)
Obstetrics 140 (5.9) 44 (9.2) 7 (5.9) – – 5.9 (5.9 to 9.2)
Gynaecology 134 (5.7) 32 (6.7) – – – 6.2 (5.7 to 6.7)
Urology 86 (3.7) – – – – –
Cardiac surgery 77 (3.3) – – – – –
Vascular surgery 71 (3.0) – – – – –
Otorhinolaryngology 59 (2.5) – – – – –
Neurosurgery 57 (2.4) – – – – –
Colorectal surgery 53 (2.3) – – – – –
Plastic surgery 49 (2.1) – – – – –
Anaesthesiology 47 (2.0) 3 (0.7) – – – 1.4 (0.7 to 2.0)
Medicine 385 (16.4) 114 (24.1) 25 (21.0) 303 (35.7) 130 (45,0) 24.1 (18.7 to 40.4)
Internal medicine 150 (6.4) 110 (23.2) – – – 14.8 (6.4 to 23.2)
Cardiology 118 (5.0) – – – – –
Paediatrics 49 (2.1) 4 (0.9) – – – 1.5 (0.9 to 2.1)
Gastroenterology 43 (1.8) – – – – –
Medical oncology 25 (1.1) – – – – –
Other 542 (23.0) 57 (11.9) – 58 (6.8) 10 (3.6) 9.4 (4.4 to 20.2)
Family practice 147 (6.2) 21 (4.4) – – – 5.3 (4.4 to 6.2)
Nursing 85 (3.6) 8 (1.7) – – – 2.7 (1.7 to 3.6)
Emergency medicine 34 (1.4) 8 (1.7) – – – 1.6 (1.4 to 1.7)
Ophthalmology 28 (1.2) – – – – –
Radiology – 5 (1) – – – –
Other 248 (10.5) 15 (3.1) – – – 6.8 (3.1 to 10.5)
Unknown 51 (2.2)
Numbers (percentages) except last column. Interquartile range=25th to 75th percentile. Wilson: numbers and percentages were given. Thomas: percentages were given, and
numbers were calculated. Vincent: numbers were given, and percentages were calculated. Davis: numbers and percentages were given. Baker: numbers were given in a crosstable
with type of event. Because AEs could be attributed to more than one type of event, the total was 360. Numbers and percentages in this table were calculated as a percentage of
the total number of AEs.
Table 5 Adverse events classified by location
Reference Brennan et al
25 Wilson et al
3 Thomas et al
2 Davis et al
24
Median percentage
(interquartile range)
No. of adverse events/total no. of records 1133/30 121 2353/14 179 475/14 700 850/6579 –
In hospital 920 (81.2) 1741 (74.0) 398 (83.8) 683 (80.4) 80.8 (75.6 to 83.2)
Operating room 465 (41.0) 1077 (45.8) 188 (39.5) – 41.0 (39.5 to 45.8)
Patient’s room 300 (26.5) 577 (24.5) 103 (21.6) – 24.5 (21.6 to 26.5)
Emergency room 33 (2.9) – 14 (3.0) – 3.0 (2.9 to 3.0)
Labour and delivery room 32 (2.8) 87 (3.7) 31 (6.5) – 3.7 (2.8 to 6.5)
Intensive care unit 31 (2.7) – 17 (3.5) – 3.1 (2.7 to 3.5)
Radiology 23 (2.0) – – – –
Cardiac catheterisation laboratory 10 (0.9) – 20 (4.2) – 2.6 (0.9 to 4.2)
Ambulatory care unit 9 (0.8) – – – –
Procedure room – – 16 (3.4) – –
Other 19 (1.7) – 10 (2.2) – 2.0 (1.7 to 2.2)
Out of hospital 156 (13.8) 297 (12.6) 76 (16.0) 167 (19.6) 14.9 (12.9 to 18.7)
Physician’s office 87 (7.7) 200 (8.5) 33 (7.0) 54 (6.4) 7.4 (6.6 to 8.3)
Patient’s home 31 (2.7) 56 (2.4) 16 (3.4) 45 (5.3) 3.1 (2.5 to 4.8)
Ambulatory care unit 16 (1.4) – – 11 (1.3) 1.4 (1.3 to 1.4)
Nursing home 10 (0.9) 41 (1.7) 3 (0.6) 32 (3.8) 1.3 (0.7 to 3.3)
Day surgery – – 6 (1.2) – –
Private hospital – – – 17 (2.0) –
Other 12 (1.1) – 18 (3.8) 8 (0.9) 1.1 (0.9 to 3.8)
Unknown 58 (5.1) 315 (13.4) 1 (0.3) – 5.1 (0.3 to 13.4)
Numbers (percentages) except last column. Interquartile range=25th to 75th percentile. Brennan: percentages were given, and numbers were calculated. Wilson: numbers and
percentages were given. Thomas: percentages were given, and numbers were calculated. Davis: percentages were given, and numbers were calculated.
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emergency team are mentioned. The medication-related prac-
tices include bar code technology and computerised physician
order entry systems.
DISCUSSION
We conducted a systematic review to gain an insight into the
overall incidence, preventability and outcome of adverse events
and added information about location, provider and type of
events. Despite the enormous amount of recent attention for
patient safety, such systematic compiling of all available
evidence on the subject is lacking to date.
This systematic review included eight studies from the USA,
Canada, the UK, Australia and New Zealand. The median
overall incidence of adverse events was 9.2%, and almost half of
these events were regarded as preventable. The majority of
Table 6 Adverse events classified by type of event
Reference Brennan et al
25 Wilson et al
3 Thomas et al
2 Vincent et al
26 Davis et al
24 Baker et al
31
Median percentage
(interquartile range)
No. of adverse events/total no. of records 1133/30 121 2952/14 179 475/14 700 118/1 014 1060/6 579 360/3 745 –
Operation-related 599 (52.9) 1159 (49.3) 213 (44.9) 40 (33.9) 258 (24.3) 123 (34.2) 39.6 (31.5 to 50.2)
Drug-related 178 (15.7) 249 (10.6) 92 (19.3) 17 (14.4) 130 (12.3) 85 (23.6) 15.1 (11.9 to 20.4)
Diagnostic 79 (7.0) 314 (13.3) 33 (6.9) 5 (4.2) 85 (8.0) 38 (10.6) 7.5 (6.2 to 11.3)
Therapeutic 62 (5.5) 276 (11.7) 21 (4.4) – 89 (8.4) – 7.0 (4.7 to 10.9)
Procedure* 88 (7.8) 197 (8.4) 64 (13.5) 6 (5.1) 82 (7.7) 26 (7.2) 7.8 (6.7 to 9.7)
Fall/fracture 38 (3.4) 192 (8.2) 8 (1.7) – – 8 (2.2) 2.8 (1.8 to 7.0)
Postpartum/obstetric 18 (1.6) 126 (5.4) 17 (3.6) – – 1 (0.3) 2.6 (0.6 to 5.0)
Anaesthesia-related 13 (1.1) 51 (2.2) 6 (1.3) 6 (5.1) – 7 (2.0) 2.0 (1.2 to 3.7)
Neonatal 29 (3.0) 30 (1.3) 15 (3.1) – – – 3.0 (1.3 to 3.1)
System{/other 29 (3.0) 358 (15.2) 7 (1.5) – 416 (39.3) 29 (8.1) 8.1 (2.3 to 27.3)
Ward management – – – 30 (25.4) – – –
Discharge – – – 14 (11.9) – – –
Other clinical management – – – – – 43 (11.9) –
Brennan: numbers were given, percentages were calculated. Wilson: numbers and percentages were given. Thomas: percentages were given, and numbers were calculated.
Vincent: numbers were given, and percentages were calculated. Davis: numbers and percentages were given. Baker: numbers were given, and percentages were calculated.
Numbers (percentages) except last column. Interquartile range=25th to 75th percentile.
*Medical procedure such as coronary angiography or endoscopy.
{Contains: defective equipment or supplies, inadequate reporting or communication, inadequate staffing, training or supervision, no protocol/failure to implement protocol.
Table 7 Interventions related to operation- and drug-related events
Type of event Intervention Highest-level study example
Level of
evidence
Operation-related Localising care to high-volume centres Halm et al. Is volume related to outcome in health care? A systematic
review
and methodologic critique of the literature. Ann Intern Med 2002
34
2A
Training programmes for laparoscopic procedures Scheeres et al. Animate advanced laparoscopic courses improve resident
operative performance. Am J Surg 2004
35
2B
Medical emergency team Bellomo et al. Prospective controlled trial of effect of medical emergency
team
on postoperative morbidity and mortality rates. Crit Care Med 2004
36
2B
Ultrasound guidance of central vein catheterisation Randolph et al. Ultrasound guidance for placement of central venous
catheters:
a meta-analysis of the literature. Crit Care Med 1996
37
1A
Prevention of surgical site
infections:
Antibiotic prophylaxis Song et al. Antimicrobial prophylaxis in colorectal surgery: a systematic
review
of randomized controlled trials. Br J Surg 1998
38
1A
Peri-operative normothermia Kurz et al. Perioperative normothermia to reduce the incidence of surgical-
wound infection and shorten hospitalization. N Engl J Med 1996
39
1B
Supplemental oxygen Greif et al. Supplemental perioperative oxygen to reduce the incidence of
surgical-wound infection. N Engl J Med 2000
40
1B
Glucose control in diabetics Furnary et al. Clinical effects of hyperglycemia in the cardiac surgery
population: the portland diabetic project. Endocr Pract 2006
41
2B
Perioperative beta blockers Devereaux et al. How strong is the evidence for the use of perioperative
beta blockers in non-cardiac surgery? Systematic review and meta-analysis
of randomised controlled trials. BMJ 2005
42
1A
Drug-related Computerised Physician Order Entry (CPOE) and Clinical
Decision Support System (CDSS)
Overhage et al. A randomized trial of ‘‘corollary orders’’ to prevent errors of
omission. J Am Med Inform Assoc 1997
43
1B
Clinical pharmacist consultation services Leape et al. Pharmacist participation on physician rounds and adverse drug
events in the intensive care unit. JAMA 1999
44
2B
Bar code technology in pharmacy Poon et al. Medication dispensing errors and potential adverse drug events
before and after implementing bar code technology in the pharmacy. Ann
Intern Med 2006
45
2B
Patient self-management of anticoagulation Cromheecke et al. Oral anticoagulation self-management and management
by a specialist anticoagulation clinic: a randomized crossover comparison.
Lancet 2000
46
1B
Error management
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than half of events were operation- or drug-related.
Although all included studies used the same definition,
incidences of adverse events varied considerably. In 2000, a
comparison was made between the Utah/Colorado study
(incidence 3.2%) and the Australian study (incidence 16.6%),
and a number of possible reasons for this difference were
provided.
47 48 There were a number of methodological differ-
ences between the studies, such as a lower threshold for
defining causation in the Australian study and inclusion of some
types of events in one study that were excluded in the other.
Aside from these differences, the authors suggest that the
disparity might be due to differences in quantity and methods
of documentation between Australia and the USA, and different
perspectives of the two studies (medicolegal versus quality-
improvement). These considerations may also apply to the
other studies included in this review. For example, both studies
that were performed from a medicolegal point of view
23 2
reported considerably lower incidences than the other studies,
performed from a quality-improvement point of view.
3 28–31 33
Furthermore, not all studies employed the same time frame for
included events. Out-of-hospital events were included in only a
few studies. Some studies only recorded one adverse event per
patient record, whereas others did not enforce this restriction.
These methodological differences may well, at least in part,
account for the difference between the recorded incidences.
Retrospective record review has been criticised for a number
of reasons. As it relies heavily on patient records, it is dependent
on the quality of documentation. If adverse events are not
documented properly, they will not be detected by this method.
Furthermore, only those adverse events are detected that result
in one of the trigger criteria of the review method. Finally, in
retrospective record review, the interobserver variability is very
high, especially with regard to the judgements on causality and
preventability.
49 The studies included in this review show
moderate interobserver agreement scores, illustrating this draw-
back of retrospective record review.
Aside from the fact that the conclusions from this review are
based solely on retrospective record review studies, and as such,
most likely represent an underestimation of the problem, there
are a number of other limitations of this systematic review, the
most important one being the heterogeneity of the included
studies. Although most studies used roughly the same methods,
the details differed considerably. For example, the studies from
Australia and New Zealand applied a lower threshold for
causation than the other studies. The time frame of included
events also differed between studies: the studies from the
United States did not include events discovered after discharge,
whereas the other included studies did. Because differences in
methodology and perspective may lead to different numbers of
recorded AEs,
47 48 we must proceed with caution when drawing
conclusions from the combined data from these studies. Apart
from differences in methodology between the included studies,
our strict inclusion criteria potentially may have caused us to
exclude interesting studies. The three studies we excluded
because of an insufficient number of patient records evaluated,
when combined, 1607 records, amounting to 2% of all records
included in this systematic review (more than 74 000 records).
The two excluded studies that used a computer-assisted
approach
78 reported incidences of adverse events that were
slightly lower (8.3% and 6.9%) than the median incidence of the
studies included in the present review. This approach is much
less time-consuming than the retrospective record review, but a
drawback is that it cannot make judgements on causation or
preventability.
Much attention is being devoted to finding solutions to
improve patient safety. In 2005, the authors of some of the
largest adverse event studies advocated the implementation of
selected evidence-based practices that have a potential for large
impact.
50 When looking at the classification of events as
demonstrated in this review, operation-related and drug-related
events together comprise the majority. It would thus be logical
to concentrate funds and efforts on evidence-based interven-
tions aimed at reducing these events. In addition to the
evidence-based interventions reviewed here, there are a number
of other interventions that seem promising but warrant further
research to prove their value. This includes interventions
derived from the aviation industry, such as crew resource
management and the use of checklists in the operating room.
In conclusion, adverse events during hospital admission are a
serious problem, occurring in approximately 9% of all admitted
patients and leading to a lethal outcome in 7% of cases. Since a
large portion of the adverse events are operation- or drug-
related, and almost half of these events are preventable, funds
and efforts should be concentrated on interventions aimed at
reducing these types of events.
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